Bulk Drug Parks and the PLI Push to Cut China Dependence

Imagine the government responding to the China API dependency covered elsewhere on this site with two genuinely complementary policy tools, a Rs 6,940 crore Production Linked Incentive scheme specifically for bulk drugs, rewarding manufacturers for actually producing critical API molecules domestically, and a separate Rs 3,000 crore Bulk Drug Parks scheme, building shared industrial infrastructure, common effluent treatment, power and logistics, specifically in Gujarat, Himachal Pradesh and Andhra Pradesh to reduce the fixed-cost barrier that has historically made bulk drug manufacturing less economically attractive in India than importing from China.

This twin approach directly addresses the two genuine obstacles that had pushed API manufacturing offshore in the first place, the PLI scheme's direct financial incentive tackles the cost gap versus Chinese imports, while the Bulk Drug Parks tackle the shared infrastructure deficit, bulk drug manufacturing requires genuinely significant environmental compliance infrastructure, covered under the industrial pollution control discussion elsewhere on this site, that individual smaller manufacturers struggled to justify building independently.

The scheme's actual progress by December 2025 shows genuine, measurable traction, 38 projects commissioned, creating roughly 56,800 metric tonnes annual capacity for identified critical products, with cumulative sales reaching Rs 2,720 crore, including Rs 527.96 crore in exports that helped avert imports valued at Rs 2,192.04 crore, figures indicating real substitution of previously imported API volume rather than merely subsidised production that doesn't actually displace Chinese imports.

This progress matters directly for assessing whether India's API self-reliance ambition is genuinely working, covered throughout this page, the import-avoidance figure specifically, Rs 2,192.04 crore in avoided imports against Rs 2,720 crore in scheme-linked sales, represents the single most important metric for judging success, since the scheme's entire strategic purpose is reducing China dependency, not simply generating additional domestic production that runs alongside continued import growth.